AF
NUVB icon

Amalgamated Financial’s Nuvation Bio NUVB Stock Holding History

Amalgamated Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$131K Buy
+24,816
New +$139K ﹤0.01% 2055

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Amalgamated Financial's NUVB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Nuvation Bio (NUVB) in Q1 2022: 24,816 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #2055 among its holdings.

117 funds tracked by Wall St. Rank hold NUVB as of Q1 2022.

  • Amalgamated Financial held 24,816 shares of Nuvation Bio worth $131K as of Q1 2022.
  • Nuvation Bio was a new Amalgamated Financial position in Q1 2022.
  • Nuvation Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2055 holding.
  • 117 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.